Task Name Target Regulatory Context Prompt Objective Required Input Data Expected Output Format Validation Method (Inferred)
510(k) Substantial Equivalence Preparation 21 CFR Part 807 Subpart E Draft a substantial equivalence comparison and summary between a subject device and predicate(s) to demonstrate safety and effectiveness. Device description, indications for use, technological characteristics, performance data, and predicate device identification. Formal 510(k) Summary or Markdown table as per 21 CFR 807.92. Review against 21 CFR 807.87, 807.92, and FDA guidance on evaluating substantial equivalence.
Quality System Audit 21 CFR Part 820 Generate an internal audit checklist or report focusing on design controls, production processes, and risk-based decision making. Quality Manual, Design History File (DHF) excerpts, SOPs, and previous audit reports. Formal audit report or Markdown checklist with regulatory citations. Verify against requirements in 21 CFR 820 (Subparts B-O) and relevant transition modules (QMSR).
Risk Management Analysis ISO 14971 / 21 CFR 820.30 Perform a risk analysis (e.g., PHA) to identify potential hazards, hazardous situations, and mitigation strategies. Intended use, design specifications, foreseeable misuse, and historical data for similar devices. Risk Analysis Matrix (Markdown table) including Hazard, Harm, Severity, and Probability. Cross-reference with ISO 14971 principles and FDA training modules on Risk Management.
IDE Application Preparation 21 CFR Part 812 Draft an Investigational Device Exemption (IDE) application, including risk analysis and investigational plans for clinical studies. Investigational plan, report of prior investigations, investigator agreements, and device labeling. Formal IDE application package following the sequence in 21 CFR 812.25. Verify inclusion of all elements required by 21 CFR 812.20 and 812.25.
Premarket Approval (PMA) Preparation 21 CFR Part 814 Draft a detailed summary of a PMA application, including clinical investigation results and manufacturing history. Clinical results, nonclinical lab data, device characteristics, and marketing history. Formal structured summary as per 21 CFR 814.20(b)(3). Review against specific summary requirements listed in 21 CFR 814.20(b)(3)(i-vi).
PMA Post-approval Reporting 21 CFR Part 814.82 / 814.84 Compile a summary of post-approval requirements, including clinical study data, manufacturing changes, and scientific literature. PMA approval order, study data, change logs, and bibliography of recent literature. Formal report to the Office of Device Evaluation. Verify compliance with 21 CFR 814.82 and 814.84 submission requirements.
Medical Device Administrative Detention Appeal 21 CFR Part 1.402 / 800.55 Draft a written appeal for an administrative detention order issued on a food item or medical device. Detention order number, date received, and verified statement of ownership/proprietary interest. Formal legal letter. Verify submission within the required timeframe (10 days for food, 5 days for devices) per 21 CFR 1.402 or 800.55.
Foreign Supplier Verification Program (FSVP) Audit 21 CFR Part 1 Subpart L Draft a summary report of an onsite audit for a foreign food supplier including conclusions and corrective actions. Audit procedures, dates, findings on processes, and records of deficiencies. Formal audit report in Markdown format. Cross-reference against 21 CFR 1.506(e)(1)(i)(D) requirements for audit documentation.
Establishment of Food Traceability Plan 21 CFR Part 1 Subpart S Create a structured traceability plan for a facility handling foods on the Food Traceability List. List of foods handled, record maintenance procedures, and contact information. Structured text document with sections for procedures and identification. Ensure all requirements of 21 CFR 1.1315(a) (1-5) are addressed.
Food Safety Audit Reporting (Regulatory) 21 CFR Part 1 Subpart M Draft a regulatory audit report for an eligible entity after a food safety audit. Facility identity (FEI), audit dates, scope, and identified deficiencies. Structured Markdown table or list. Verify that all 9 specific data elements listed in 21 CFR 1.652(b) are present.
Directed Food Laboratory Order Verification 21 CFR Part 1 Subpart R Review a Directed Food Laboratory Order to identify mandatory testing parameters. FDA issued Directed Food Laboratory Order. Key-value list of product, environment, methods, and timeframes. Compare parameters with specifications in 21 CFR 1.1108(b).
Import Entry Data Element Compilation 21 CFR Part 1 Subpart D Compile required identifying information (510(k), UFI, NDC, NDA) for electronic import entry of drugs or devices. Clearance documentation, registration numbers, and listing information. JSON object or alphanumeric string. Check compliance with 21 CFR 1.74(a) and 1.76(c) for ACE system mapping.
Automated Image Assessment System 510(k) 21 CFR 866.2190 Draft a detailed device description for an automated image assessment system for microbial colonies. Technology details, software modules, and expert rules for colony assessment. Formal technical document. Verify content against requirements in 21 CFR 866.2190(b)(1)-(5).
Special Controls Labeling Compliance 21 CFR 866.3169 Generate mandatory labeling content, including warnings and limitations, for HCV antibody tests. Specimen types, clinical population data, and performance characteristics. Structured labeling text. Cross-check warnings against requirements in 21 CFR 866.3169(b)(1).
Zika Virus Reagent Study Design 21 CFR 866.3935 Draft a protocol for analytical performance studies to validate Zika virus serological reagents. Reference material details, cross-reactivity targets, and specimen stability. Technical study protocol. Ensure protocol covers analytical studies mandated by 21 CFR 866.3935(b)(2)(ii).
Carrier Screening System 510(k) 21 CFR 866.5940 Compile technical information for an autosomal recessive carrier screening gene mutation detection system. Gene list (HUGO), variant coordinates, and clinical validity evidence. Comprehensive technical summary report. Check against technical info requirements in 21 CFR 866.5940(b)(3)(i).
Design Verification for BCR-ABL Tests 21 CFR 866.6060 Outline design verification and validation requirements for a BCR-ABL quantitation test. Variant types, IS conversion methodology, and calibration control data. Validation checklist or matrix. Review against submission requirements in 21 CFR 866.6060(b)(1).
NGS Tumor Profiling Documentation 21 CFR 866.6080 Develop documentation supporting the clinical significance of mutations in an NGS-based tumor profiling panel. Somatic mutations, professional guidelines, and method comparison data. Tabulated summary of mutations categorized by evidence levels. Confirm categorization aligns with criteria in 21 CFR 866.6080(b)(1)(v).
Civil Money Penalties Hearing Response 21 CFR Part 17 Draft a formal 'Answer' to an FDA complaint seeking civil money penalties. FDA Complaint, alleged violations, and mitigating factors. Formal legal pleading. Review against required contents for an Answer specified in 21 CFR 17.9.
Clinical Chemistry Device Classification 21 CFR Part 862 Identify classification and regulatory requirements (general/special controls) for a clinical chemistry device. Device name and intended use. Structured summary identifying FDA Class and regulatory section. Verify classification against 21 CFR Part 862 Subparts A-D.
iCGM Clinical Testing Strategy 21 CFR 862.1355 Draft a clinical study plan to demonstrate accuracy for an iCGM system. Sensor specifications, target population, and wear period details. Formal clinical study protocol outline. Compare against performance bounds listed in 21 CFR 862.1355(b)(1).
Citizen Petition Preparation 21 CFR Part 10.30 Draft a Citizen Petition requesting administrative action by the Commissioner. Factual/legal grounds, action requested, and environmental impact assessment. Structured petition following 21 CFR 10.30(b)(3) format. Verify all required sections (Grounds, Certification, etc.) are present.
Medical Device Reporting (MDR) 21 CFR Part 803 Summarize an adverse event for mandatory electronic submission or develop an MDR SOP. Incident reports, outcome data, and device identification. Structured summary (eMDR) or numbered SOP document. Review against reporting requirements in 21 CFR Part 803 and 803.17.
UDI GUDID Submission 21 CFR Part 830 Prepare a Device Identifier (DI) record for GUDID submission. Device label, packaging levels, and GTIN data. Structured data list matching GUDID fields. Cross-check fields against GUDID DI Record preparation modules.
Freedom of Information Act (FOIA) Request 21 CFR Part 20 Draft a request for records regarding a specific 510(k) clearance. Description of records sought and requester contact information. Formal letter following 21 CFR 20.40. Check against 'Search for Records' criteria in Part 20 Subpart C.
RTA Checklist Preparation FDA RTA Policy Annotate the RTA checklist with page numbers and sections where requirements are addressed in a 510(k). Draft 510(k) submission and appropriate FDA RTA checklist. Annotated checklist with a comment column. Verify cited page numbers correspond to final submission PDF.
Intended Use and Indications for Use Alignment 21 CFR Part 801.4 Review 510(k) drafts to ensure 'Intended Use' and 'Indications for Use' are verbatim and consistent. Full 510(k) draft including labeling and executive summary. Consistency report identifying discrepancies. Cross-reference all labeling statements for exact matches.
Shelf-life Study Rationale 21 CFR Part 801 Draft a rationale for correlating accelerated aging data with real-time requirements. Material stability data, packaging type, and aging protocols. Formal technical report. Evaluate against FDA standards for shelf-life testing.
Labeling Compliance Audit 21 CFR Part 801 Audit device labeling for compliance with mandatory elements (Manufacturer, UDI, date formats). Product labels, symbols glossary, and 21 CFR 801 text. Gap analysis report. Inspect label against 21 CFR 801.1 and 801.18.
21 CFR Part 14 Auditing 21 CFR Part 14 Audit advisory committee meeting minutes for compliance with record-keeping elements. Minutes, attendee list, and information considered. Markdown compliance checklist. Verify presence of items listed in 21 CFR 14.60(b).
Humanitarian Device Exemption (HDE) 21 CFR Part 814 Subpart H Explain why the health benefit of a HUD outweighs the risk of injury. HUD designation and risk-benefit analysis of alternatives. Formal narrative explanation. Check against HDE contents specified in 21 CFR 814.104(b)(3).
Quality System Evaluation (MRA) 21 CFR 820 / MRA Subpart B Generate a quality system evaluation report for a manufacturer under the US-EC MRA. Onsite inspection data and manufacturing records. Full or abbreviated Quality System Evaluation Report. Cross-reference with Joint Sectoral Committee specifications.
PMA Supplement (CBE) 21 CFR 814.39(d) Draft a 'Special PMA Supplement - Changes Being Effected' for safety warnings. New safety information and current labeling. Formal letter marked 'Special PMA Supplementâ€”CBE'. Compare against criteria in 21 CFR 814.39(d)(1)-(2).
De Novo Request Preparation 21 CFR Part 860 Subpart D Generate a summary of risks and mitigations for a De Novo classification request. Probable risks and proposed mitigation measures. Structured table or list. Review against 21 CFR 860.220(a)(9).
Correction and Removal Reporting 21 CFR Part 806 Draft a written report to FDA for a device correction or removal. UDI, event description, and consignee list. Formal report following 21 CFR 806.10(c)(1). Cross-check fields against 21 CFR 806.10 mandatory info list.
Reclassification Petitioning 21 CFR Part 860 Subpart C Prepare a statement of the basis for disagreement with a current device classification. Device type, requested action, and scientific evidence. Formal petition document. Assess if evidence meets standards in 21 CFR 860.7.
Public Hearing Participation 21 CFR Part 12 Complete a Notice of Participation for a formal evidentiary public hearing. Docket number, contact info, and specific interests. Standardized form (21 CFR 12.45). Confirm submission within 30 days of hearing notice.
Privacy Act Auditing 21 CFR Part 21.20 Draft a notice for a new FDA Privacy Act Record System. System name, location, and categories of individuals. Federal Register notice format. Compare against requirements in 21 CFR 21.20(b)(1-11).
Informed Consent Exception (Emergency) 21 CFR Part 50.24 Draft IRB documentation for an exception from informed consent in emergency research. Clinical protocol and community consultation plans. IRB justification document. Check against 21 CFR 50.24 criteria (a)(1) through (a)(7).
GLP Quality Assurance 21 CFR Part 58.35 Prepare a statement for a nonclinical study report certifying inspection dates. Master schedule, protocol, and inspection records. Signed QA Statement. Verify inclusion of dates as required by 21 CFR 58.35(b)(7).
Patent Term Restoration Eligibility 21 CFR Part 60 Determine if a medical product's review period qualifies for patent term restoration. Marketing approval date, patent number, and chronology. Formal eligibility assessment letter. Verify calculation logic against 21 CFR 60.10 and 60.22.
IRB Protocol Review 21 CFR Part 56 Evaluate a clinical investigation protocol to ensure it meets IRB approval criteria. Clinical protocol and informed consent forms. Checklist of compliance items. Verify against approval criteria in 21 CFR 56.111.
Medical Device Recall Strategy 21 CFR Part 810 / Part 7 Develop a mandatory recall strategy for a device posing health risks. Health hazard evaluation and distribution lists. Structured strategy document. Review against 21 CFR 810.14 and 7.42.
Off-Label Information Dissemination 21 CFR Part 99 Prepare a mandatory disclosure statement for disseminating peer-reviewed articles on unapproved uses. Journal article and cleared labeling. Prominently displayed warning statement. Confirm statement matches verbatim requirements in 21 CFR 99.103.
Part 11 Closed System Audit 21 CFR Part 11 Audit a software supplier's closed system for electronic record integrity. Record retrieval protocols and audit trail logs. Audit report with checklist. Compare system features against 21 CFR 11.10.
Financial Disclosure Certification 21 CFR Part 54 Identify required financial disclosure forms and draft attestations for clinical investigators. Payment records and equity interest data. FDA Form 3454/3455 or formal letter. Cross-reference thresholds ( $25k/$ 50k) against records.
Parallel Review Request FDA/CMS Program Draft an email requesting enrollment in the Parallel Review program. Regulatory history and public health impact statement. Formal professional email. Check against the five enrollment criteria for CDRH/CMS.
Combination Product Jurisdiction 21 CFR Part 3 Prepare a Request for Designation (RFD) to identify primary FDA jurisdiction. Product composition and Primary Mode of Action (PMOA). Formal 15-page (max) RFD letter. Review PMOA determination against 21 CFR 3.2(m).
Medicare Coverage Request (IDE) CMS Guidelines Prepare a request packet for CMS reimbursement of an IDE study. FDA IDE approval letter and NCT number. CMS request letter and crosswalk table. Verify against the 10 regulatory Medicare coverage criteria.
Cyber Device Security Plan FD&C Act 524B Draft a postmarket cybersecurity plan and Software Bill of Materials (SBOM). Software architecture and list of components. Technical documentation for eSTAR. Check against FDA Cybersecurity guidance.
Human Factors/Usability Summary FDA HF Guidance Summarize usability testing results to demonstrate minimized use-related risks. Usability test protocols and summative data. Markdown table or narrative summary. Review against 'Applying Human Factors' guidance and IEC 62366.
